bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report)’s share price rose 38.1% during trading on Thursday . The company traded as high as $0.4093 and last traded at $0.2230. 12,401 shares traded hands during trading, an increase of 125% from the average daily volume of 5,518 shares. The stock had previously closed at $0.1615.
bioAffinity Technologies Stock Performance
The stock has a 50 day simple moving average of $0.18 and a two-hundred day simple moving average of $0.23.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
See Also
- Five stocks we like better than bioAffinity Technologies
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
-logo.png){kind=logo}
